Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition To Shuffle Leadership Team At AGM

Thu, 25th Apr 2019 14:13

LONDON (Alliance News) - Neuroscience firm Cambridge Cognition Holdings PLC on Thursday announced a change of leadership at its upcoming annual general meeting.

Cambridge Cognition's meeting will be held on May 23.

Chief Executive Steve Powell will step down from the role, but continue as a non-executive director and as chair. Newly-appointed Chief Operating Officer Matthew Stork will become CEO.

Leaving at the AGM will be current Non-Executive Chair Michael Lewis and Non-Executive Director Nicholas Kerton.

Cambridge Cognition is planning on appointing another non-executive director within three months.

Powell commented: "Mike Lewis and Nick Kerton were both appointed as directors of the company in April 2013 as the company listed on AIM. Mike has been chair of the board since May 2014 and Nick was chief executive officer from September 2013 until the end of 2015."

"Both Mike and Nick retire from the company with our thanks for their service over the past six years."

"Matthew and I have had the benefit of working together for the past few months and Matthew inherits an exciting and innovative business which has made good progress in penetrating its core cognitive assessment and digital health markets," outgoing CEO Powell continued.

"Matthew's experience in healthcare and pharmaceuticals will bring a fresh commercial perspective to the business and we will be working together to accelerate the growth of the business."

Shares were 0.8% lower on Thursday at a price of 65.50 pence each.

More News
23 Oct 2014 09:08

Cambridge Cognition Launches New Product CTIS-Profile 2+

Read more
29 Sep 2014 11:54

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
24 Sep 2014 08:58

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
11 Sep 2014 10:21

Cambridge Cognition Narrows Pretax Loss In First-Half

Read more
13 Aug 2014 09:28

Cambridge Cognition Expands Partnership With Altreos Research

Read more
2 Jul 2014 08:50

Cambridge Cognition To Meet Full-Year Expectations As Half Year Ahead

Read more
26 Jun 2014 09:50

Cambridge Cognition Confident For Full-Year On Contract Wins

Read more
5 Jun 2014 09:34

Cambridge Cognition Holdings Signs Contracts For Cognitive Safety Trial

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that it has signed a contract for a global multi-year study in which its Cantab Solutions technology will be used to assess the cognitive safety of a new medicine under development for cardiovascular disease. The contra

Read more
3 Jun 2014 08:12

Cambridge Cognition Launches First iPad Product For Clinical Trials

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Tuesday that it had launched the first of its two iPad-based products on its Cantab Connect digital platform for use in clinical trials. Its product, called The Clinical Trials Information System Adverse Effects, allows for the

Read more
28 May 2014 10:08

Cambridge Cognition rolls out new health app in Lincolnshire

Computerised neuropsychological test specialists Cambridge Cognition announced its Cantab Mobile app has been released by North East Lincolnshire Clinical Commissioning Group into the medical sector. The group's app will be introduced to five GP surgeries, five pharmacies and Grimbsy hospital to he

Read more
28 May 2014 10:00

Cambridge Cognition Mobile App Rolled Out In North East Lincolnshire

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that the North East Lincolnshire Clinical Commissioning Group has introduced its Cantab mobile app in five GP surgeries, five pharmacies and Grimsby hospital to help diagnose dementia earlier. The firm, which specialis

Read more
8 May 2014 11:58

Cambridge Cognition Reiterates Confidence On Return To Growth

LONDON (Alliance News) - Cambridge Cognition Holdings PLC Thursday reiterated confidence that it would be able to return to growth in 2014, in a statement ahead of its annual general meeting. The biotechnology company said that it had seen a positive start to trading in the first quarter of

Read more
2 Apr 2014 10:29

Cambridge Cognition Appoints Non-Executive Chairman

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday it has appointed Michael Lewis as non-executive Chairman. The company, which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, said Lewis will take over from

Read more
13 Mar 2014 12:08

Cambridge Cognition Confident For Return To Growth In 2014

LONDON (Alliance News) - Cambridge Cognition Holdings PLC expressed confidence Thursday that it would return to growth in 2014, after it posted a widened pretax loss in 2013 due to lower revenue. Cambridge Cognition provides computerised neuropsychological tests, particularly to enable earl

Read more
3 Mar 2014 11:00

Cambridge Cognition Launches Latest Research Software

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Monday it has launched the Cantab Research Suite, the latest offering in its cognitive testing platform for academic research. Cambridge, which specialises in computerised neuropsychological tests, such as those enabling the ear

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.